216 related articles for article (PubMed ID: 33823772)
1. Liposomes: An Emerging Approach for the Treatment of Cancer.
Mishra K; Jain AK
Curr Pharm Des; 2021; 27(20):2398-2414. PubMed ID: 33823772
[TBL] [Abstract][Full Text] [Related]
2. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
3. Liposomal Drug Delivery Systems and Anticancer Drugs.
Olusanya TOB; Haj Ahmad RR; Ibegbu DM; Smith JR; Elkordy AA
Molecules; 2018 Apr; 23(4):. PubMed ID: 29662019
[TBL] [Abstract][Full Text] [Related]
4. Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy.
Zou J
Environ Res; 2023 Dec; 238(Pt 1):117111. PubMed ID: 37734579
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review.
Abbasi H; Rahbar N; Kouchak M; Khalil Dezfuli P; Handali S
J Liposome Res; 2022 Jun; 32(2):195-210. PubMed ID: 33729077
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
8. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
9. Liposomal Nanotechnology for Cancer Theranostics.
Yue X; Dai Z
Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
[TBL] [Abstract][Full Text] [Related]
10. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
Andresen TL; Jensen SS; Jørgensen K
Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
[TBL] [Abstract][Full Text] [Related]
11. Ligand-targeted liposomes for cancer treatment.
Sapra P; Tyagi P; Allen TM
Curr Drug Deliv; 2005 Oct; 2(4):369-81. PubMed ID: 16305440
[TBL] [Abstract][Full Text] [Related]
12. Liposomes for Tumor Targeted Therapy: A Review.
Wang S; Chen Y; Guo J; Huang Q
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768966
[TBL] [Abstract][Full Text] [Related]
13. Receptor mediated tumor targeting: an emerging approach for cancer therapy.
Mohanty C; Das M; Kanwar JR; Sahoo SK
Curr Drug Deliv; 2011 Jan; 8(1):45-58. PubMed ID: 21034422
[TBL] [Abstract][Full Text] [Related]
14. Drug and gene co-delivery systems for cancer treatment.
Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
[TBL] [Abstract][Full Text] [Related]
15. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
[TBL] [Abstract][Full Text] [Related]
16. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
17. Liposomes in the treatment of malignancy: a clinical perspective.
Sugarman SM; Perez-Soler R
Crit Rev Oncol Hematol; 1992; 12(3):231-42. PubMed ID: 1497823
[TBL] [Abstract][Full Text] [Related]
18. Pros and cons of the liposome platform in cancer drug targeting.
Gabizon AA; Shmeeda H; Zalipsky S
J Liposome Res; 2006; 16(3):175-83. PubMed ID: 16952872
[TBL] [Abstract][Full Text] [Related]
19. Future directions of liposome- and immunoliposome-based cancer therapeutics.
Park JW; Benz CC; Martin FJ
Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
[TBL] [Abstract][Full Text] [Related]
20. Current trends in the use of liposomes for tumor targeting.
Deshpande PP; Biswas S; Torchilin VP
Nanomedicine (Lond); 2013 Sep; 8(9):1509-28. PubMed ID: 23914966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
